# The Application of Artificial Intelligence and Machine Learning in Left Ventricular Assist Device Implantation: A Systematic Review

## TL;DR

This paper reviews how AI and machine learning can improve left ventricular assist device implantation by predicting risks and outcomes, though challenges remain.

## Contribution

A systematic review of AI/ML applications in LVAD implantation, identifying key areas of use and persistent challenges.

## Key findings

- ML models outperformed traditional methods in predicting mortality and adverse events.
- AI/ML showed superior accuracy in predicting myocardial recovery and thrombosis risk.
- Right ventricular failure prognostication improved using ML with hemodynamic and imaging data.

## Abstract

This systematic review evaluates the current evidence pertaining to the application of artificial intelligence (AI) and machine learning (ML) in left ventricular assist device (LVAD) implantation. Specifically, the potential of AI/ML in risk stratification, predicting complications, and improving patient outcomes is explored, whereas also identifying key challenges and elucidating avenues of future research.

A comprehensive search was conducted across EMBASE, MEDLINE, Cochrane, PubMed, and Google Scholar databases to identify studies on AI/ML in LVAD implantation up to March 2024. Articles were selected if they utilized AI/ML techniques in LVAD settings and met predefined criteria. A total of 17 studies were included after a rigorous screening and appraisal process.

The included studies highlighted the use of ML in five main areas: (1) mortality prediction, where ML models demonstrated higher accuracy compared to traditional models; (2) adverse event prediction, including aortic regurgitation and suction events; (3) myocardial recovery, with ML models outperforming traditional stratification methods; (4) deciphering thrombosis risk, with ML identifying key predictors such as younger age and higher BMI; and (5) right ventricular failure prognostication, within which ML models leveraged hemodynamic and imaging data for superior prediction accuracy. Despite such prevalent advances, challenges including data heterogeneity, lack of causality, and limited generalizability persist.

AI and ML possess transformative potential in optimizing LVAD management, offering both advanced prediction of commonly encountered risk occurrence and personalized care respectively. However, identified issues in AI/ML application, including data interpretability, dataset diversity, and integration into clinical workflows, must be addressed in order to enhance their broader adoption and impact.

This systematic review explores the application of artificial intelligence and machine learning in left ventricular assist device implantation, highlighting their superior accuracy in predicting mortality, adverse events, myocardial recovery, thrombosis risk, and right ventricular failure. Despite promising outcomes, challenges like data heterogeneity, interpretability, and clinical integration remain, necessitating further research for broader adoption.